{"disease":{"id":"neuroendocrine-tumor-gep-grade-1-3","name":"neuroendocrine tumor gep grade 1 3"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06981455","title":"Life Following Excision of Neuroendocrine Tumors","phase":"","overall_status":"RECRUITING","enrollment_count":246,"lead_sponsor_name":"Sunnybrook Health Sciences Centre","has_results":false},{"nct_id":"NCT07185672","title":"PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":162,"lead_sponsor_name":"Tata Memorial Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}